On-demand medicine manufacturing secures supply 'whether on the battlefield or hospital' - CPHI Frankfurt preview
CPHI caught up with Eugene Choi to discuss point-of-care medicine manufacturing ahead of his CPHI Frankfurt presentation
Over the course of the past few years, the pandemic has shone a light on issues in pharmaceutical supply chains and underscored the fragility of global transportation networks. When global lockdowns were imposed, many countries experienced a surge in demand for pharmaceuticals and a concurrent supply crunch. When COVID-19 vaccines were rolled out a year later, facilitating cold chain transportation became a huge issue in some developing countries.
To overcome supply chain challenges and increase patient access, On Demand Pharmaceuticals is creating technology platforms that enable point-of-care medicine manufacturing. This will be the subject of a presentation by On Demand’s Chief Technology Officer, Eugene Choi, at CPHI Frankfurt this year.
The session, titled On-Demand Manufacturing for Medicine Supply Chain Resiliency & Patient-Ready Medicine Delivery, will discuss the modular automated systems the company produces that can produce raw materials to finished drug product, enabling patient access ‘whether on the battlefield or hospital’. Eugene’s presentation will take place on November 3 – Register for CPHI Frankfurt now.
Eugene Choi, Chief Technology Officer, On Demand Pharmaceuticals
What will your session at CPHI Frankfurt focus on?
The title of my talk is "On-demand manufacturing for medicine supply chain resiliency and patient-ready medicine delivery". At On Demand Pharmaceuticals, we are creating technology platforms that enable point-of-care medicine manufacturing and supply whether on the battlefield or hospital.
In your session, you explore the possibilities of point-of-care medicine manufacturing. What potential applications do you see for this?
With constrained global supply chains for medicines and medicine components, we believe point-of-care medicine manufacturing and supply provides the agility required to provide immediate drug security and mitigate drug shortages for hospitals and clinicians. Longer term, we see potential applications in customizing and personalizing medicines and dosages that is catered to the individual patient.
Since the start of the COVID pandemic, supply chain resilience has been on everyone’s mind. How could on-demand medicine manufacturing strengthen supply and increase patient access?
Imagine not relying on multiple manufacturing, distribution, and transportation channels to access your medicines. Instead, imagine if your medicine was handed to you within a few minutes or hours when you needed them. That is our vision - that hospitals and clinicians don't ever have to worry about accessing their medicines.
Why are you attending CPHI Frankfurt? What benefit do you get from the event?
I've been to CPHI Frankfurt in the past, and I have enjoyed making new connections, maintaining old contacts, and staying up to date on the latest and greatest. It is such a great global event that brings together stakeholders from all over the world.
We have a packed agenda of content and networking opportunities at this year’s event. What are you most looking forward to?
I'm looking forward to gleaning what's on people's minds within the industry…what pain points and challenges folks are facing and where can synergies be created to solve problems.
CPHI’s new brand line is ‘At the Heart of Pharma’ - what does that mean to you? Does that represent what it feels like to attend a CPHI event?
Since CPHI covers the entire medicine supply chain from active ingredients to finished drug product to innovative pharmaceutical technologies, it really is at the heart of pharma.
Related News
-
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Streamlined Development for Efficient Production of Bispecific Molecules: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv... -
News MDR – How to collect post-market clinical follow-up data (PMCF): Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio... -
News Sourcing Responsibly – putting ESG principles into practice: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Enric Bosch, Global Third Party manager, Chemicals at Boehringer Ingelheim (Barcelona, Spain), investigates the growing shift towards environmental, social, and governance (ESG) principles and how to put responsibl... -
News Operational excellence in technology transfer: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Clarissa J. Van Allen, Global Senior Manager, Technology Transfer, Oral Solid Dose at Thermo Fisher Scientific (Des Moines, USA), discusses the value of an effective and efficient technology transfer project in the... -
News Connect to Frankfurt - Five reasons to tune in
Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. -
News CPHI North America Lookahead: Facilitating ‘meaningful conversations’ on needs and solutions
CPHI NA takes place as a SMART event this year, with online learning and networking from May 9-27 and an in-person event from May 17-19 in Philadelphia, PA. -
News Early development demand continues to boost prospects for smaller CDMOs: CPHI Worldwide panel
The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPHI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance